Calcipotriene and Betamethasone Dipropionate
These highlights do not include all the information needed to use safely and effectively. See Full Prescribing Information for . Initial U.S. Approval: 2006
Approved
Approval ID
174c5378-f2b9-4e9e-931a-4123137be62d
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 7, 2023
Manufacturers
FDA
Bryant Ranch Prepack
DUNS: 171714327
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Calcipotriene, Betamethasone Dipropionate
PRODUCT DETAILS
NDC Product Code63629-2520
Application NumberANDA200174
Marketing CategoryC73584
Route of AdministrationTOPICAL
Effective DateJanuary 10, 2022
Generic NameCalcipotriene, Betamethasone Dipropionate
INGREDIENTS (6)
CALCIPOTRIENEActive
Quantity: 50 ug in 1 g
Code: 143NQ3779B
Classification: ACTIB
BETAMETHASONE DIPROPIONATEActive
Quantity: .643 mg in 1 g
Code: 826Y60901U
Classification: ACTIM
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
PPG-15 STEARYL ETHERInactive
Code: 1II18XLS1L
Classification: IACT
.ALPHA.-TOCOPHEROL, DL-Inactive
Code: 7QWA1RIO01
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT